Epigenetic regulation of DOT1L methyltransferase activityremodels lipid metabolism to alleviate ferroptosis-induced liver injury.
Epigenetic modifications contribute to lipid-related disorders by modulating the expression of key genes involved in lipid metabolism. Accumulating evidence suggests that lipid metabolism-mediated ferroptosis drives the progression of metabolic associated steatohepatitis (MASH) and liver injury. However, whether epigenetic mechanisms remodel lipid metabolism to regulate ferroptosis-induced liver damage remains unclear. Here, through pharmacological screening of epigenetics-related compounds and CRISPR-Cas9-based screening targeting epigenetic factors, we identified DOT1 Like Histone Lysine Methyltransferase (DOT1L) as a key sensitizer of hepatocytes to ferroptosis and subsequent liver injury, whereas inhibition of DOT1L reverses the phenomenon. DOT1L loss remodeled the phospholipid landscape by decreasing PUFA-containing phospholipids while increasing monounsaturated and lysophospholipid species. Mechanistically, DOT1L depletion reduced H3K79me1 and H3K79me2 occupancy at the PLA2G7, ALDH3B1, and PLCXD3 loci, particularly across gene-body regions, while increasing promoter-proximal accessibility and expression of these phospholipid-remodeling genes. These genes suppress ferroptosis by reducing the levels of phospholipids containing polyunsaturated fatty acids (PL-PUFAs). Furthermore, we demonstrated that AMPK phosphorylates DOT1L at Ser786, weakens its association with AF9, and suppresses H3K79 methyltransferase activity and ferroptosis sensitivity. Collectively, our findings reveal the AMPK-DOT1L-H3K79 methylation axis as a novel lipid metabolic pathway that regulates ferroptosis and maintains hepatic homeostasis, offering new therapeutic insights for ferroptosis-related liver injury.
Authors
- Bo Chu (ORCID: https://orcid.org/0000-0001-9754-2743)
- Dandan Song (ORCID: https://orcid.org/0000-0003-3898-9232)
- Wei Jun Gu (ORCID: https://orcid.org/0000-0002-1480-2368)
- Rong‐Rong He (ORCID: https://orcid.org/0000-0001-5505-5672)
- Yi-Jia Gao
- Zongli Zhang (ORCID: https://orcid.org/0000-0002-9501-3757)
- Chang Pan (ORCID: https://orcid.org/0000-0003-2098-4265)
- Zheng‐Ze Pan (ORCID: https://orcid.org/0000-0001-7021-6147)
- Jiaming Hu (ORCID: https://orcid.org/0000-0001-5028-3123)
- Ziyang Zhang (ORCID: https://orcid.org/0000-0001-5870-704X)
- Xiao Zhuang
- Jiaxing Liu (ORCID: https://orcid.org/0000-0001-9691-8470)
- WanYang Sun
- Shuo Liu
- Rong Wang
- Xiang-Chuang Fan
- Yun-Fei Xu
- Wei-Wei Cui
- Ya-Jing Han
Institutions
- Beijing Institute of Technology (CN)
- Shandong University (CN)
- Jinan University (CN)
- Aerospace Center Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Columbia University (US)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1172/jci205758
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00